论文部分内容阅读
目的 :观察奥曲肽和垂体后叶素联用酚妥拉明治疗食管胃底静脉曲张破裂出血 (EVB)的临床疗效和副作用。方法 :将5 4例EVB患者分为 :奥曲肽组 (治疗组 ) 2 8例 ,垂体后叶素联用酚妥拉明组 (对照组 ) 2 6例。结果 :3天内总止血率治疗组85 .71% ,对照组 84.6 2 % ,差异无显著性 (P >0 .0 5 ) ;对照组副作用 34 .6 2 % ,明显高于治疗组 3.5 7% (P <0 .0 1)。结论 :奥曲肽治疗食管胃底静脉曲张破裂出血疗效肯定 ,副作用少。
Objective: To observe the clinical efficacy and side effects of octreotide and pituitrin combined with phentolamine in the treatment of esophageal variceal bleeding (EVB). Methods: Fifty-four patients with EVB were divided into two groups: 28 in the octreotide group (treatment group) and 26 in the pituitrin combined with phentolamine group (control group). Results: In the 3 days, the total hemostasis rate was 85.71% in the treatment group and 84.6% in the control group, with no significant difference (P> 0.05). The side effects of the control group were 34.62%, significantly higher than the 3.57% (P <0. 01). Conclusion: Octreotide is effective in treating esophageal variceal bleeding with few side effects.